Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer—More Insights, but More Questions-Reference-Cited by-同舟云学术

Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer—More Insights, but More Questions

Published:2007-06-01 Issue:16 Volume:25 Page:2152-2155
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Forastiere Arlene A.¹,Burtness Barbara A.²

Affiliation:

1. Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD

2. Fox Chase Cancer Center, Philadelphia, PA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.10.9017

Reference25 articles.

1. Grandis JR, Tweardy DJ: Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53:3579,1993-3584,

2. Ang KK, Berkey BA, Tu X, et al: Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62:7350,2002-7356,

3. Prognostic value of the epidermal growth factor receptor (EGRF) and p53 in advanced head and neck squamous cell carcinoma patients treated with induction chemotherapy

4. Pollack VA, Savage DM, Baker DA, et al: Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: Dynamics of receptor inhibition in situ and antitumor effects in athymic mice. J Pharmacol Exp Ther 291:739,1999-748,

5. Epidermal Growth Factor Receptor Family and Chemosensitization

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGF‑IL2 bispecific and bivalent EGF fusion toxin efficacy against syngeneic head and neck cancer mouse models;Oncology Reports;2022-12-27

2. A novel diphtheria toxin‐based bivalent human EGF fusion toxin for treatment of head and neck squamous cell carcinoma;Molecular Oncology;2021-02-20

3. Fisetin induces apoptosis in breast cancer MDA‐MB‐453 cells through degradation of HER2/neu and via the PI3K/Akt pathway;Journal of Biochemical and Molecular Toxicology;2018-11-15

4. Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial;Supportive Care in Cancer;2017-12-11

5. Changes in cell junctions induced by inhibition of epidermal growth factor receptor in oral squamous cell carcinoma cells;Experimental and Therapeutic Medicine;2017-06-14